The most interesting fact is that we postulated expression analysis of SERTAD1 in breast cancer and we observed reciprocal results (high expression of SERTAD1 revealed higher overall survival, n = 626, Logrank test p = 0.1259) from other cancers. Here, SERTAD1 is linked to breast cancer.